文献速递急性肾损伤慢性肾脏病血液净化与透析

肾脏病中的临床药代动力学:基本原理

Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-06-22

本文综述肾脏病对药物药代动力学的影响及剂量调整原则。肾脏病降低药物清除率,分布容积可变或增加;急性肾损伤时变化动态且恢复可能,肾脏替代治疗增加复杂性。应用药代动力学原理可估算或定量调整剂量,实现个体化用药并减少剂量不当的不良事件。

要点

  • 肾脏病降低药物清除率,分布容积可不变或增加。
  • 急性肾损伤药代动力学变化动态,恢复取决于病因和治疗。
  • 应用药代动力学原理可估算剂量调整,减少剂量不当事件。

核心结论

  • 理解并应用药代动力学原理对肾脏病个体化给药至关重要,可减少剂量不足或过量导致的不良事件。

研究设计与样本

  • 综述,讨论肾脏病中影响给药方案设计的药代动力学基本原理。

主要发现

  • 肾脏病降低药物清除率,分布容积可不变或增加。
  • 慢性肾脏病变化相对缓慢,急性肾损伤变化动态且恢复可能取决于病因和治疗。
  • 肾脏替代治疗进一步增加急性肾损伤时量化药物清除的难度。

临床怎么用

  • 处方时应结合药物知识、患者生理改变程度和药代动力学原理设计或调整剂量。
  • 现有肾脏病剂量指南可能基于有限数据或适用性不广,需理解原理并灵活应用。
  • 对急性肾损伤及使用肾脏替代治疗者,应重新评估药物清除并个体化调整剂量。

局限性

  • 现有肾脏病剂量指南可能基于有限数据或适用性不广。
  • 个体生理改变程度难以界定,急性肾损伤时药物清除量化尤其复杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Kidney disease is an increasingly common comorbidity that alters the pharmacokinetics of many drugs. Prescribing to patients with kidney disease requires knowledge about the drug, the extent of the patient's altered physiology, and pharmacokinetic principles that influence the design of dosing regimens. There are multiple physiologic effects of impaired kidney function, and the extent to which they occur in an individual at any given time can be difficult to define. Although some guidelines are available for dosing in kidney disease, they may be on the basis of limited data or not widely applicable, and therefore, an understanding of pharmacokinetic principles and how to apply them is important to the practicing clinician. Whether kidney disease is acute or chronic, drug clearance decreases, and the volume of distribution may remain the same or increase. Although in CKD, these changes progress relatively slowly, they are dynamic in AKI, and recovery is possible depending on the etiology and treatments. This, and the use of kidney replacement therapies further complicate attempts to quantify drug clearance at the time of prescribing and dosing in AKI. The required change in the dosing regimen can be estimated or even quantitated in certain instances through the application of pharmacokinetic principles to guide rational drug dosing. This offers an opportunity to provide personalized medical care and minimizes adverse drug events from either under- or overdosing. We discuss the principles of pharmacokinetics that are fundamental for the design of an appropriate dosing regimen in this review.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Lea-Henry TN, Carland JE, Stocker SL, et al. Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles. Clin J Am Soc Nephrol. 2018. PMID: 29934432. doi:10.2215/CJN.00340118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。